Golgi antiapoptotic protein (GAAP) is a novel regulator of cell death that is highly conserved in eukaryotes and present in some poxviruses, but its molecular mechanism is unknown. Given that alterations in intracellular Ca 2؉ homeostasis play an important role in determining cell sensitivity to apoptosis, we investigated if GAAP affected Ca 2؉ signaling.
INTRODUCTION
Recently, a novel regulator of cell death was identified (Gubser et al., 2007) . This protein was named Golgi antiapoptotic protein (GAAP) because of its predominant localization in the Golgi and its ability to suppress apoptosis. GAAP is a predicted seven-transmembrane protein and was identified initially in certain poxviruses (vaccinia virus and camelpox virus) where it affects virus virulence. GAAPs are highly conserved in a broad range of organisms including human, orangutan, dog, mouse, rat, Xenopus laevis, and zebrafish, and related proteins are present in Drosophila and Arabidopsis. Human (h)-GAAP is expressed ubiquitously in human tissue and shares 73% aa identity with viral (v)-GAAP. Stable expression of either v-GAAP or h-GAAP suppressed cell death induced by a broad variety of intrinsic and extrin-sic apoptotic stimuli. Conversely, knockdown of h-GAAP in tissue culture cells by siRNA resulted in cell death.
Ca 2ϩ functions as a ubiquitous intracellular signal to many different biological processes. Ca 2ϩ -induced signaling arises from Ca 2ϩ entry across the plasma membrane and/or release from intracellular stores, predominantly the endoplasmic reticulum (ER) and Golgi. Ca 2ϩ is released from intracellular stores by inositol-1,4,5-trisphosphate (IP 3 ), which interacts with IP 3 receptors (IP 3 Rs) that are Ca 2ϩ release channels present in the ER and Golgi . Furthermore, IP 3 R activity is modulated by Ca 2ϩ itself, ATP, phosphorylation, and interacting proteins (Foskett et al., 2007) . Ca 2ϩ that enters the cytosol activates cytosolic enzymes and is taken up by mitochondria, which play an important role in decoding Ca 2ϩ signals during normal cell physiology . Mitochondrial Ca 2ϩ uptake is mediated by a low-affinity Ca 2ϩ uniporter that senses the high Ca 2ϩ microdomains that are established at the tight junctions between the ER and mitochondria . Recently, tight junctions with a putative role in Ca 2ϩ signaling were also observed between Golgi and mitochondria (Dolman et al., 2005) .
Alterations in the finely tuned intracellular Ca 2ϩ homeostasis and compartmentalization contribute to the induction of apoptosis. The switch from the control of physiological functions to the involvement in this death program most likely entails changes in the tightly regulated spatiotemporal Ca 2ϩ signaling pattern affecting cytosolic effector proteins and effector organelles (Orrenius et al., 2003) . Ca 2ϩ signaling between storage organelles and mitochondria plays an important role in sensitizing cells to apoptosis (Pinton and Rizzuto, 2006) . Molecular and pharmacological approaches that lowered Ca 2ϩ levels in the stores and thereby reduced Ca 2ϩ signaling to the mitochondria, protected cells from apoptosis, whereas conditions that increased Ca 2ϩ levels in the stores had the opposite effect (Ma et al., 1999; Nakamura et al., 2000; Pinton et al., 2001; Pinton and Rizzuto, 2006) . Moreover, both antiapoptotic (e.g., Bcl-2 and Bcl-X L ) and proapoptotic (e.g., Bax and Bak) partially localize at the ER to regulate Ca 2ϩ signaling (Oakes et al., 2003; Chen et al., 2004; White et al., 2005) .
On the basis of the localization of h-GAAP at intracellular Ca 2ϩ stores and the established importance of intracellular Ca 2ϩ signaling in sensitizing cells to apoptosis induction, we hypothesized that the antiapoptotic role of h-GAAP may be mediated by modulating the Ca 2ϩ content of these stores and/or the flux of Ca 2ϩ between these stores and the closely opposed mitochondria. Here, evidence is presented that h-GAAP alters intracellular Ca 2ϩ fluxes induced by both a physiological stimulus (histamine) and an apoptotic stimulus (staurosporine).
MATERIALS AND METHODS

Cells and Medium
U2OS-neo and U2OS-h-GAAP cell lines were described previously (Gubser et al., 2007) . Cells were grown in minimal essential medium (Invitrogen, Carlsbad, CA) supplemented with 10% (vol/vol) fetal bovine serum and 10 g/ml Ciproxin (Bayer, Newbury, Berks, United Kingdom) at 37°C in a 5% CO 2 atmosphere.
Antibodies, Conjugates, and Reagents
Mouse monoclonal antibodies against IP 3 R3, calnexin, Bcl-2, and paxillin were obtained from BD Transduction Laboratories (Lexington, KY). Mouse mAb against protein disulfide isomerase (PDI) was from StressGen (San Diego, CA), against Bcl-XL from Santa Cruz Biotechnology (Santa Cruz, CA) and against ␣-tubulin from Upstate Laboratories (Lake Placid, NY). Rabbit polyclonal antibodies against Bax and Bak were from Cell Signaling Technology (Beverly, MA). Rabbit polyclonal antibody (Rbt 476) against IP3R (all isoforms) was described previously (Ma et al., 2002) . Coelenterazine-W, coelenterazine-N, fura-2 acetoxymethyl ester (fura-2/AM), and Rhod-2/AM were from Molecular Probes (Eugene, OR), histamine and ionomycin from Sigma-Aldrich (Poole, Dorset, United Kingdom), 2-APB from Calbiochem (La Jolla, CA), and STS from Roche (East Sussex, United Kingdom).
RNA Interference
Sequences of small interfering RNA1 (siRNA1) and siRNA2 (Ambion, Austin, TX) were described previously (Gubser et al., 2007) . Cells were grown to 50% confluency in six-well plates and transfected with 1 g of each of the above siRNAs using siFECTamine (IC-Vec; www.icvec.com) according to the manufacturer's instructions.
Immunoprecipitation
Coimmunoprecipitation was performed as described for Bcl-2 interaction with IP 3 R (Chen et al., 2004) . Abs used were anti-IP 3 R3 Ab (BD Biosciences, Poole, United Kingdom; 1:200), anti-HA mAb (1:200) and the control Ab used was a mouse IgG2a Ab-1 (Stratech Scientific, Bedfordshire, United Kingdom; 1:150). Proteins were resolved by SDS-PAGE and transferred onto Hybond-P PVDF membranes (Amersham, Bucks, United Kingdom).
Digital Imaging Microscopy of Cytosolic and Mitochondrial Ca 2؉ Concentrations
Cells (3 ϫ 10 5 ) seeded on 24-mm glass coverslips were coloaded with 3 M fura-2/AM and 5 M rhod-2 AM for 25 min at 37°C and used for monitoring simultaneous changes in mitochondrial and cytosolic Ca 2ϩ concentration as described (Visch et al., 2004) . The fura-2 and rhod-2 dyes were excited at 380 and 540 nm, respectively. The fura-2 fluorescence emission ratio at 492 nm was monitored as a measure of the free cytosolic Ca 2ϩ concentration after alternating excitation at 340 and 380 nm. In all experiments, the fluorescence emission signal was normalized to its prestimulatory value, which was set at 1.
Luminescence Monitoring of Ca 2؉
For luminescence measurement of Ca 2ϩ , 5 ϫ 10 4 cells were seeded on 13-mm glass coverslips, transfected with targeted aequorin using FuGENE 6 reagent (Roche), and analyzed as described (Visch et al., 2004; Visch et al., 2006) . 45 Ca 2ϩ fluxes were performed as described (Kasri et al., 2006) . Briefly, cells were grown to confluency, permeabilized with saponin, loaded with 45 Ca 2ϩ , and washed with efflux medium containing 4 M thapsigargin (TG) to block ATP-dependent Ca 2ϩ uptake. IP 3 -stimulated Ca 2ϩ release was initiated by the addition of efflux medium containing the indicated concentration of IP 3 , and 2 min later the efflux medium was collected and counted for radioactivity. After correction for the passive leak induced by TG alone, the amount of radioactivity released by IP 3 was expressed as a percentage of the total amount of radioactivity present in the stores as determined by addition of the Ca 2ϩ ionophore A23187. To assess the rate of passive Ca 2ϩ leakage induced by TG alone, the efflux medium was replaced every 2 min during 18 min. At the end of the experiment, all residual radioactivity was released by incubation with 1 ml of 2% SDS for 30 min. For each data point, the amount of radioactivity that was still present in the stores was calculated, expressed as a percentage of the total amount present at the onset of the experiment, and plotted as a function of time.
Ca 2؉ Fluxes
Calculations
Data are presented as mean values Ϯ SEM. Differences were tested for significance using the Student's t test.
RESULTS
h-GAAP Decreases Cytosolic and Mitochondrial Ca 2؉ Rises Triggered by an Apoptotic Stimulus
In this study, possible effects of h-GAAP on intracellular Ca 2ϩ signaling were investigated using U2OS cells that stably expressed hemagglutinin (HA)-tagged h-GAAP predominantly at the Golgi but also at the ER (hereafter referred to as h-GAAP cells; Gubser et al., 2007) . Essentially the same results were obtained with two independently constructed h-GAAP cell lines. Except in experiments in which parental U2OS cells were transfected with siRNA, U2OS cells containing the empty plasmid vector were used as a control (hereafter referred to as U2OS-neo cells). Western blot analysis was performed to exclude the possibility that h-GAAP overexpression affected the expression levels of ER chaperones or Bcl-2 family members. The data show that the expression levels of calnexin, PDI, Bcl-2, Bcl-X L , Bax, and Bak in h-GAAP cells was not altered compared with U2OS-neo cells (Supplementary Figure S1 ).
Previously, staurosporine (STS)-induced apoptosis was demonstrated to be partially, but significantly, inhibited in h-GAAP cells (Gubser et al., 2007) . The exact mechanism by which STS induces cell death is unknown, but STS-induced cell death is at least partially Ca 2ϩ -dependent (Oakes et al., 2003; Chen et al., 2004; White et al., 2005) . Therefore, we first addressed a possible role of h-GAAP in the STS-induced changes in intracellular Ca 2ϩ homeostasis (Boehning et al., 2003) . To this end, cells were coloaded with the cytosolic Ca 2ϩ indicator fura-2 and the mitochondrial Ca 2ϩ indicator rhod-2, treated with STS, and analyzed by digital imaging microscopy. Initial measurements of the resting cytosolic Ca 2ϩ concentration using fura-2 revealed no detectable differences between U2OS-neo and h-GAAP cells (resting fura-2 ratio in U2OS-neo cells was 0.35 Ϯ 0.02, n ϭ 85 cells, measured on 5 d; resting fura-2 ratio in h-GAAP was 0.35 Ϯ 0.01, n ϭ 85 cells, measured on 5 d). On addition of 2 M STS, U2OS-neo cells displayed a gradual increase in both mitochondrial and cytosolic Ca 2ϩ concentration ( Figure 1, A  and B ). Both increases were virtually abolished by 2-aminoethoxy-diphenylborate (2-APB), a drug that suppresses extracellular Ca 2ϩ entry by inhibiting store-operated Ca 2ϩ channels and indicating that STS acts to stimulate the capac-itative entry of extracellular Ca 2ϩ (Peppiatt et al., 2003) . Similarly, no increases were observed when using Ca 2ϩ -free medium (data not shown). Importantly, expression of h-GAAP strongly reduced the STS-induced increase in both mitochondrial and cytosolic Ca 2ϩ concentration.
To gain further support for a role of h-GAAP in regulating STS-induced Ca 2ϩ fluxes, we next assessed the effect of h-GAAP down-regulation. Parental U2OS cells were transfected with siRNA1 (hereafter referred to as h-GAAP siRNA) or siRNA2 (hereafter referred to as control siRNA), shown before to decrease h-GAAP or be without effect on h-GAAP expression, respectively (Gubser et al., 2007) . Cells were tested for their response to STS at 2 d after transfection, at which time they were shown before to be still alive (Gubser et al., 2007) . Cells transfected with h-GAAP siRNA showed a much larger STS-induced increase in mitochondrial and cytosolic Ca 2ϩ concentration than untreated U2OS-neo cells (Figures 1, A and B ) or parental U2OS cells treated with either control siRNA or transfection reagent alone (data not shown). Also in h-GAAP siRNA-treated cells, the STS-induced increase in mitochondrial and cytosolic Ca 2ϩ concentration was virtually completely inhibited by 2-APB. These results show that h-GAAP reduces the STSinduced increase in mitochondrial and cytosolic Ca 2ϩ concentration, which depends on the influx of Ca 2ϩ across the plasma membrane.
h-GAAP Decreases Histamine-induced Rises in Cytosolic and Mitochondrial Ca 2؉
To gain more insight into a possible role of h-GAAP in the regulation of intracellular Ca 2ϩ signaling, we investigated its effects on the increase in cytosolic and mitochondrial Ca 2ϩ concentration evoked by the IP 3 -generating hormone histamine. To prevent capacitative Ca 2ϩ entry, stimulation with histamine was performed in the absence of extracellular Ca 2ϩ , i.e., after dye-loading, cells were washed in Ca 2ϩ free medium, transferred to Ca 2ϩ free medium containing 0.5 mM EGTA, and stimulated with histamine 1 min later. Under these conditions, 100 M histamine evoked a transient rise in cytosolic Ca 2ϩ concentration, the amplitude of which was significantly reduced in h-GAAP cells ( Figure  1C ). Moreover, the upstroke of the Ca 2ϩ transient induced by histamine appeared slower in h-GAAP cells than in U2OS-neo cells. To test the effects of h-GAAP on histamineinduced mitochondrial Ca 2ϩ uptake, cells were transfected with a mitochondrial-targeted variant of the Ca 2ϩ -sensitive photoprotein aequorin. Resting Ca 2ϩ levels in the mitochondrial matrix were not significantly altered in h-GAAP cells (U2OS-neo cells, 0.038 Ϯ 0.010 M, n ϭ 10 coverslips, measured on 3 d; h-GAAP cells, 0.034 Ϯ 0.009 M, n ϭ 14 coverslips, measured on 3 d). Histamine evoked a transient increase in mitochondrial Ca 2ϩ concentration, the amplitude of which was significantly decreased in h-GAAP cells (p Ͻ 0.05; Figure 1D ). Western blotting using an IP 3 R antibody that recognizes all three subtypes revealed no detectable differences in the amount of IP 3 R in U2OS-neo and h-GAAP cells ( Figure 1E ). These results indicate that h-GAAP can reduce the histamine-induced increase in mitochondrial and cytosolic Ca 2ϩ concentration, mediated by IP 3 Rs and, in this case, depending solely on the release of Ca 2ϩ from intracellular stores.
h-GAAP Coimmunoprecipitates with the IP 3 R
The above results suggested that h-GAAP might interact with IP 3 Rs thus providing a potential explanation for its inhibitory effect on the flux of Ca 2ϩ through these receptors. Because currently there exists no good antibody against h-GAAP for immunoprecipitation purposes, we made use of Figure 1 . h-GAAP reduces staurosporine and histamine-induced Ca 2ϩ rises in the cytosol and the mitochondria. (A and B) Fura-2 and rhod-2 coloaded cells were excited alternately at 380 and 540 nm for digital imaging microscopy of the STS (2 M)-induced changes in rhod-2 (A) and fura-2 (B) fluorescence, respectively, in the absence or presence of 2-APB. STS was added at 120 s after the onset of monitoring. The fluorescence emission signal was normalized to its prestimulatory value. Typical records depicting changes in mitochondrial and cytosolic Ca 2ϩ are shown (average of 13 cells is shown). In B, the scale representing the fura-2 380-nm fluorescence is inverted to give a more intuitive representation of the rise in cytosolic Ca 2ϩ . (C) Fura-2-loaded cells seeded on glass coverslips were treated with 100 M histamine and changes in cytosolic Ca 2ϩ were monitored by digital imaging microscopy. In each experiment, the fluorescence emission ratio was normalized to its prestimulatory value, which was set at 1. Left, typical records depicting changes in cytosolic Ca 2ϩ (average of 30 -40 cells is shown); right, the average Ϯ SEM of the peak amplitude from three independent experiments performed in duplicate. * p Ͻ 0.05, *** p Ͻ 0.001. (D) Luminescence analysis of histamine-induced changes in Ca 2ϩ concentration in the mitochondrial matrix of neo and GAAP cells transfected with mitochondrion-targeted aequorin. * p Ͻ 0.05. (E) IP 3 R expression levels in neo and h-GAAP cells lysates were determined by immunoblotting using an antibody recognizing all three IP 3 R isoforms. Proteins were resolved by using 4 -15% linear gradient SDS-PAGE.
the HA-tag that was fused to h-GAAP. The results obtained show that the anti-HA mAb coprecipitated IP 3 R subtype 3 (IP 3 R3; Figure 2A ), which is the most abundant subtype in U2OS cells (data not shown). The specificity of this reaction was confirmed by the failure of the antibody to precipitate any sarcoendoplasmic reticulum Ca 2ϩ -ATPase isoenzyme 2b (SERCA2b), the predominant SERCA protein in nonmuscle cells. In the reciprocal experiment, immunoprecipitation of IP 3 R3 brought down h-GAAP ( Figure 2B ). These results demonstrate that h-GAAP interacts, either directly or indirectly, with the IP 3 R.
h-GAAP Alters the IP 3 -induced Ca 2؉ Release Response from Intracellular Ca 2؉ Stores in Permeabilized Cells
Because h-GAAP can be coprecipitated with IP 3 Rs, we next assessed the possibility that it might affect the characteristics of the IP 3 -induced Ca 2ϩ release response. To gain access to the IP 3 R, we made use of a permeabilized cell system. Cells were permeabilized with saponin, loaded to steady state with 45 Ca 2ϩ , washed to remove excess ATP using an efflux medium containing the SERCA inhibitor TG to prevent Ca 2ϩ -reuptake, and challenged with either the Ca 2ϩ ionophore A23187, to determine total releasable 45 Ca 2ϩ or the indicated concentration of IP 3 . After 2 min, the time required for completion of the rapid phase of the IP 3 -induced Ca 2ϩ release response, the medium was removed, and the amount of 45 Ca 2ϩ released was determined, corrected for passive 45 Ca 2ϩ leakage, and expressed as percentage of total re-leasable 45 Ca 2ϩ . Maximum stimulation with IP 3 released a significantly smaller fraction of total releasable Ca 2ϩ in h-GAAP cells (p Ͻ 0.005, Figure 2C ). The latter finding was not likely to be due to a decrease in the number of IP 3 Rs because immunoblot analysis of cell lysates revealed no detectable difference in expression of the most abundant subtype 3 (Figure 2A) .
Calculation of the EC 50 value showed that h-GAAP did not affect the sensitivity for IP 3 (1.35 Ϯ 0.33 and 1.28 Ϯ 0.14 M IP 3 for U2OS-neo and h-GAAP cells, respectively). We observed a small effect of h-GAAP on the cooperativity of the IP 3 -induced Ca 2ϩ release response, as measured by calculation of the Hill coefficient (1.22 Ϯ 0.22 and 1.02 Ϯ 0.15 for U2OS-neo and h-GAAP cells, respectively), but this difference was not statistically significant. These results indicate that h-GAAP decreases the efficacy of IP 3 without altering its potency. It remains to be established whether this involves a direct or indirect interaction between h-GAAP and IP 3 Rs.
h-GAAP Lowers the Amount of Stored Ca 2؉ in Intact Cells
Next, we measured the steady-state Ca 2ϩ content of IP 3 Rregulated Ca 2ϩ stores in intact cells expressing h-GAAP. To this end, cells were loaded with the cytosolic Ca 2ϩ indicator fura-2, transferred to a Ca 2ϩ free medium, and treated either with the Ca 2ϩ ionophore ionomycin (1 M) or the SERCA inhibitor BHQ (20 M). Because the Ca 2ϩ content of these stores is maintained by a pump-leak system, SERCA inhibi- tion will lead to passive release of stored Ca 2ϩ into the cytosol. The results show that both BHQ ( Figure 3A ) and ionomycin ( Figure 3B ) evoked a transient rise in cytosolic Ca 2ϩ concentration, the amplitude of which was significantly reduced in h-GAAP cells. Importantly, and in contrast to what was observed with histamine, the upstroke of the Ca 2ϩ transients induced by BHQ and ionomycin was unaltered in h-GAAP cells.
To investigate the effects of h-GAAP on the Ca 2ϩ concentration in ER and Golgi separately, cells were transfected with organelle-targeted aequorins, permeabilized with saponin at 20 h after transfection, and assayed for ATP-dependent Ca 2ϩ uptake under "cytosolic" conditions at a free Ca 2ϩ concentration of 0.1 M. In both organelles the steadystate Ca 2ϩ concentration appeared lower (ϳ20%) in h-GAAP cells (p Ͻ 0.01, Figure 3 , C and D). Importantly, no major differences in the initial rate of Ca 2ϩ uptake were observed, indicating that h-GAAP does not alter the SERCA pump capacity of the intracellular stores.
To establish more firmly that h-GAAP has an effect on the steady-state Ca 2ϩ content of the intracellular stores, we next determined this content at different times after transfection of parental U2OS cells with h-GAAP siRNA. Comparison with parental U2OS cells transfected with control siRNA revealed no detectable difference at 20 h after transfection ( Figure 3E ). At 40 h after transfection, however, the amplitude of the ionomycin-induced increase in cytosolic Ca 2ϩ concentration was significantly higher (ϳ35%) in h-GAAP down-regulated cells (p Ͻ 0.001). Organelle-targeted aequorins revealed that this increase in Ca 2ϩ concentration occurred in both ER and Golgi (p Ͻ 0.05, Figure 3F ).
hGAAP Decreases the Sensitivity to Histamine Induction of Oscillatory Cytosolic Ca 2؉ Changes
In the experiments described thus far, cells were stimulated with a "pharmacological" concentration of histamine (100 M). In the remainder of this study, we assessed the possible consequences of these findings on Ca 2ϩ signaling in intact cells under more "physiological" conditions. Cells were loaded with fura-2 and superfused with medium containing (sub)micromolar concentrations of histamine. Digital imaging microscopy of individual cells revealed that 0.3 and 1.0 M histamine increased the cytosolic Ca 2ϩ concentration in ϳ70 and ϳ95% of the U2OS-neo cells, respectively. For h-GAAP cells, these values were ϳ20 and ϳ70%, respectively, indicating a reduced sensitivity to hormonal induction of an increase in cytosolic Ca 2ϩ concentration. In a small percentage of the responding U2OS-neo cells (ϳ5-10% at 1.0 M histamine), the initial large Ca 2ϩ transient was followed by Ca 2ϩ oscillations (Figure 4, A and B) . These Ca 2ϩ oscil- lations were observed only rarely in the h-GAAP cells, indicating that the occurrence of these oscillations is prevented in these cells. Taken together, these data are in agreement with the idea that h-GAAP reduces IP 3 R activity in intact cells.
We also tested the effect of h-GAAP down-regulation on cytosolic Ca 2ϩ signaling. Parental U2OS cells transfected with either h-GAAP siRNA or control siRNA were monitored for histamine-induced oscillatory Ca 2ϩ changes at 2 d after transfection (Figures 4, C and D) . About ϳ5 and ϳ30% of control siRNA-transfected cells, displayed oscillatory Ca 2ϩ changes in response to 0.3 and 1.0 M histamine, respectively. Similar percentages were observed in nontransfected parental U2OS cells (data not shown). Treatment with h-GAAP siRNA significantly increased the sensitivity of parental U2OS cells to histamine induction of oscillatory changes in cytosolic Ca 2ϩ concentration (ϳ25 and ϳ45% responding cells at 0.3 and 1.0 M histamine, respectively; p Ͻ 0.05). Noticeably, a small number of cells responded already to a relatively low concentration of 0.1 M histamine and, occasionally, even spontaneous Ca 2ϩ oscillations were observed (data not shown).
DISCUSSION
In this study, evidence is presented that h-GAAP, a novel regulator of cell death, reduces both extracellular Ca 2ϩ influx evoked by staurosporine, a widely used apoptosis inducer, and intracellular Ca 2ϩ release evoked by, histamine, known to exert its effect on intracellular Ca 2ϩ through IP 3 .
Using a permeabilized cell system, which allows experimental control of the cytosolic compartment, h-GAAP over-expression was demonstrated to lower the efficacy of IP 3 , as demonstrated by a reduction of the maximum amount of total (A23187-) releasable Ca 2ϩ that could be released by IP 3 . Because neither the amount of IP 3 Rs nor their affinity for IP 3 were detectably altered in h-GAAP-overexpressing cells, this result suggests that h-GAAP either decreases the IP 3sensitive part of the (A23187-) releasable Ca 2ϩ store or, alternatively, decreases the Ca 2ϩ release properties of the IP 3 -channels. In intact cells, h-GAAP overexpression was shown to reduce the amount of total (ionomycin-or BHQ-) releasable Ca 2ϩ , consistent with a reduced filling state of the intracellular stores. Consistent with the above results, the cytosolic and mitochondrial Ca 2ϩ increases in response to a pharmacological histamine concentration (100 M) were down-regulated in intact cells overexpressing h-GAAP and up-regulated when h-GAAP was knocked down. Furthermore, stimulation with a more close to physiological concentration of histamine (1 M) revealed that h-GAAP rendered cells less sensitive to the induction of cytosolic Ca 2ϩ oscillations, characteristic for these low concentrations of histamine. Together, these data suggest that h-GAAP reduces both the total amount of releasable Ca 2ϩ and its maximum amount that can be released by IP 3 , thereby attenuating IP 3 -induced cytosolic and mitochondrial Ca 2ϩ signaling.
How h-GAAP exerts these effects remains to be established. In this study, we showed that h-GAAP inhibits the influx of extracellular Ca 2ϩ influx and decreases the IP 3mediated release of Ca 2ϩ from the stores. In addition, we showed that h-GAAP coprecipitated with IP 3 Rs, suggesting an interaction. Such an interaction, which may be either direct or indirect, could be involved in the ability of h-GAAP to suppress Ca 2ϩ fluxes. However, the observed effects of h-GAAP may equally well be explained by its ability to reduce the filling state of the Ca 2ϩ stores. Therefore, the importance of this interaction for the observed function of h-GAAP requires further investigation.
A reduction in Ca 2ϩ filling state of the intracellular stores is usually associated with an increase in capacitative Ca 2ϩ entry across the plasma membrane, resulting in an increase in cytosolic Ca 2ϩ concentration. However, under resting conditions no such increase in cytosolic Ca 2ϩ concentration was observed in cells overexpressing h-GAAP, despite a decrease in the amount of total releasable Ca 2ϩ . This result suggests that h-GAAP exerts an inhibitory effect on the process of capacitative Ca 2ϩ entry. In agreement with this idea, the STS-induced increase in cytosolic and mitochondrial Ca 2ϩ concentration, which depended completely on the presence of extracellular Ca 2ϩ and was abolished by 2-APB, an inhibitor of capacitative Ca 2ϩ entry channels, was decreased in cells overexpressing h-GAAP and was increased in cells in which this protein was down-regulated. STS and histamine increased the cytosolic Ca 2ϩ concentration with different kinetics, a relatively slow increase after addition of STS versus a relatively fast increase after stimulation with histamine. In contrast to STS, histamine readily increased the cytosolic Ca 2ϩ concentration in the absence of extracellular Ca 2ϩ , reflecting the IP 3 -induced release of Ca 2ϩ from intracellular stores. The present finding that h-GAAP lowers the histamine-induced increase in cytosolic Ca 2ϩ concentration in the absence of external Ca 2ϩ strongly supports the idea that GAAP exerts its effect by reducing the IP 3 R-mediated release of Ca 2ϩ from intracellular stores. In doing so, h-GAAP likely also reduces the capacitative entry of Ca 2ϩ . It remains to be established whether a similar mechanism underlies the inhibitory effect of h-GAAP on the STS-induced entry of extracellular Ca 2ϩ .
The ability of h-GAAP to interfere with intracellular Ca 2ϩ signaling provides a plausible explanation for its ability to suppress apoptosis. This idea is supported by observations that modulation of IP 3 R activity (by antisense knockdown, genetic deletion, or using a cell-permeable inhibitory peptide that interferes with the IP 3 R-cytochrome c interaction) rendered cells less sensitive to apoptosis triggered by both intrinsic and extrinsic pathways (Joseph and Hajnoczky, 2007) . Moreover, Bcl-2 and Bcl-X L , two major antiapoptotic proteins, interact with the IP 3 R and alter its activity, though in opposite ways: Bcl-2 decreases the IP 3 R opening probability, whereas Bcl-X L increases it (Oakes et al., 2003; Chen et al., 2004; White et al., 2005) . The mechanism by which alterations in cellular Ca 2ϩ handling sensitize or protect cells from apoptosis are as yet incompletely understood. Decreases in the amount of Ca 2ϩ available for signaling may prevent cytotoxic Ca 2ϩ fluxes between the stores and the cytosol and/or the mitochondria. Cell death-regulating proteins have also been linked to cellular metabolism (Hammerman et al., 2004; Kim et al., 2005; Skulachev, 2006) . The ability of Bcl-X L to increase the IP 3 R opening probability was shown to elevate Ca 2ϩ oscillations, resulting in enhanced mitochondrial activity and cellular bioenergetics under steady-state conditions (White et al., 2005) . h-GAAP may suppress apoptosis by down-regulating cytosolic and/or mitochondrial Ca 2ϩ rises. Exactly how h-GAAP modulates intracellular Ca 2ϩ signaling and suppresses apoptosis remains to be elucidated. The observation that h-GAAP is present in an immunoprecipitable complex with the IP 3 R and modulates IP 3 -induced Ca 2ϩ signaling does not necessarily imply that it acts directly on the IP 3 R. h-GAAP may be part of a larger IP 3 R complex comprising also Bcl-2 and/or Bcl-XL and may exert its effects on Ca 2ϩ homeostasis through this complex.
In conclusion, h-GAAP is a novel protein that that modulates both capacitative Ca 2ϩ entry and IP 3 -mediated Ca 2ϩ release. Altogether, these data show that h-GAAP has an important role in the cross-talk between the intracellular Ca 2ϩ stores, the cytosol and the mitochondria, and this may explain how h-GAAP plays a decisive role in regulating cell death by apoptosis.
